The Sound<br>of Silence

The Sound
of Silence

Desyncra™ – Rewiring the brain

Desyncra™ for Tinnitus: HCP

Tinnitus exerts a heavy burden on the patients, their families and society as a whole. It exchanges the silence that we all take for granted, for an agonizing and often ongoing sound that follows wherever you go. Despite the fact that millions suffer from tinnitus, traditional therapies only cover up the problem, they don’t solve it.

Desyncra for Tinnitus targets tinnitus on the basis of CR® Neuromodulation and user individual patterns of therapeutic tones for treatment.

Key facts Desyncra™ For Tinnitus:

  • Moderate to severe tinnitus
  • Sustained tinnitus therapy
  • Customized using proprietary algorithms
  • Proprietary software and hardware
  • FDA clearance and CE Mark
  • Diagnostic software on PC, diagnostic and therapeutic software on iPod with earphones
  • Treatment takes place over a minimum of 36 weeks
  • CR® Neuromodulation of auditory cortex
  • Robust portfolio of clinical publications
  • Great interest in the medical world

Desyncra™ For Tinnitus was conceived at Forschungszentrum Jülich, Germany’s world renowned research center.

 

4.000 patients successfully treated

Doctors and clinics around the world have already adopted Desyncra™ For Tinnitus to huge great success.

What is CR® Neuromodulation?

Under certain circumstances groups of cells form a cluster in the brain, synchronize and become hyperactive which causes, among others, tinnitus, tremors and pain. CR® Neuromodulation stimulates the cell cluster to desynchronize and abandon their pathological behaviour. Due to neuronal plasticity the obtained effects are long-lasting – suggesting a cure for patients, not just the form of symptom control that they have been limited to with hearing aids & other masking devices.

High-quality treatment

Desyncra aim to produce complete and personalized treatments for a range of patients. With precise diagnosis through high-density EGI EEG and remote, real-time monitoring for you via our fully integrated software and fully compliant servers, you can be certain that your patients are getting high-quality treatment, symptom relief and the formation of new neural pathways.

4000 patients successfully treated

Doctors and clinics around the world have already adopted Desyncra For Tinnitus to great success. More than 4000 patients experience reduced symptoms lasting beyond the therapy period. Many of these patients reported that their tinnitus completely disappeared.

Turning an iPod into a medical device

The Desyncra therapy is delivered using a customized iPod device with custom designed earphones. The therapeutic tones are tailored to the patient’s exact tinnitus profile.

Comfort and Convenience

The individualized therapy is optimally adjusted to ensure the therapeutic tones are quiet and yet audible. This allows patients to carry on with everyday life while receiving the therapy in the background. Additionally, patients have the freedom to choose which times of day they undergo therapy.

You want to know more about Desyncra™ For Tinnitus? Please visit our patient’s site!

Brain imaging shows reduced delta wave activity

What’s the cause for tinnitus?

Recent developments in neuroscience have led to a clearer understanding of the neuronal activity behind tinnitus. Neurons in the auditory cortex become hyperactive and synchronized, which is perceived by patients as tinnitus.

Desyncra™ for Tinnitus applies CR® Neuromodulation to disrupt or “desynchronize” the pathological, neuronal behaviour. Improved symptoms are reflected in EEG imaging, showing reduced delta wave activity across tinnitus neural networks.

Targeting tinnitus

Recent developments in neuroscience have led to a clearer understanding of the neuronal activity behind tinnitus. Neurons in the auditory cortex become hyperactive and synchronized, which is perceived by patients as tinnitus.

Desyncra for Tinnitus applies CR® Neuromodulation to disrupt or “desynchronize” the pathological, neuronal behaviour. Improved symptoms are reflected in EEG imaging, showing reduced delta wave activity across tinnitus neural networks.

Research has revealed that the hyperactivity behind tinnitus can be observed in the auditory cortex. The auditory cortex is physically organized according to the pitch of sounds that it perceives; from low to high. Desyncra has developed a proprietary pitch-matching procedure to make use of this by targeting the therapy to the hyperactive region in the auditory cortex.

Beyond tinnitus

CR® Neuromodulation therapy offers solutions beyond tinnitus to other neurological pathologies, including Parkinson’s disease, epilepsy and migraine. The mode of delivery is quite different for each of these neurological conditions. Nevertheless, in each case the CR® Neuromodulation is designed to target & disrupt the synchronized activity directly in the brain.

Research worldwide

Desyncra research is global, including the US and in particular Veterans Affairs Portland, and has centres in England, Switzerland and Germany.

Reduced tinnitus symptoms

The therapy usually takes 36 weeks. Patients report long-term improvement in symptoms, including reduced loudness, and annoyance and a changed pitch in tinnitus tones. Work is on-going to consider the same high-level response rates and treatment effectiveness over shorter durations.